Literature DB >> 28828680

LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.

Cynthia Santillan1, Kathryn Fowler2, Yuko Kono3, Victoria Chernyak4.   

Abstract

The Liver Imaging Reporting and Data System (LI-RADS) was designed to standardize the interpretation and reporting of observations seen on studies performed in patients at risk for development of hepatocellular carcinoma (HCC). The LI-RADS algorithm guides radiologists through the process of categorizing observations on a spectrum from definitely benign to definitely HCC. Major features are the imaging features used to categorize observations as LI-RADS 3 (intermediate probability of malignancy), LIRADS 4 (probably HCC), and LI-RADS 5 (definite HCC). Major features include arterial phase hyperenhancement, washout appearance, enhancing capsule appearance, size, and threshold growth. Observations that have few major criteria are assigned lower categories than those that have several, with the goal of preserving high specificity for the LR-5 category of Definite HCC. The goal of this paper is to discuss LI-RADS major features, including definitions, rationale for selection as major features, and imaging examples.

Entities:  

Keywords:  CT; Hepatocellular carcinoma; LI-RADS; Liver; MRI

Mesh:

Substances:

Year:  2018        PMID: 28828680     DOI: 10.1007/s00261-017-1291-4

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  11 in total

Review 1.  LI-RADS 2017: An update.

Authors:  Ania Z Kielar; Victoria Chernyak; Mustafa R Bashir; Richard K Do; Kathryn J Fowler; Donald G Mitchell; Milena Cerny; Khaled M Elsayes; Cynthia Santillan; Aya Kamaya; Yuko Kono; Claude B Sirlin; An Tang
Journal:  J Magn Reson Imaging       Date:  2018-04-06       Impact factor: 4.813

2.  Performance of Gd-EOB-DTPA-enhanced MRI for the diagnosis of LI-RADS 4 category hepatocellular carcinoma nodules with different diameters.

Authors:  Qi Tang; Cong Ma
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

Review 3.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.

Authors:  Victoria Chernyak; Kathryn J Fowler; Aya Kamaya; Ania Z Kielar; Khaled M Elsayes; Mustafa R Bashir; Yuko Kono; Richard K Do; Donald G Mitchell; Amit G Singal; An Tang; Claude B Sirlin
Journal:  Radiology       Date:  2018-09-25       Impact factor: 11.105

4.  Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study.

Authors:  Zheng Ye; Hanyu Jiang; Jie Chen; Xijiao Liu; Yi Wei; Chunchao Xia; Ting Duan; Likun Cao; Zhen Zhang; Bin Song
Journal:  Chin J Cancer Res       Date:  2019-10       Impact factor: 5.087

5.  The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging: Correlation with pathology and dynamic CT.

Authors:  Bohyun Kim; Jei Hee Lee; Jai Keun Kim; Hye Jin Kim; Young Bae Kim; Dakeun Lee
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

6.  Challenging liver lesions in noncirrhotic patients: Report of three cases.

Authors:  Tania Franceschini; Deborah Malvi; Lorenzo Maroni; Matteo Ravaioli; Matteo Cescon; Antonia D'Errico; Francesco Vasuri
Journal:  Ther Adv Gastrointest Endosc       Date:  2019-05-06

7.  Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model.

Authors:  Michal Mauda-Havakuk; Andrew S Mikhail; Matthew F Starost; Elizabeth C Jones; Baktiar Karim; David E Kleiner; Ari Partanen; Juan A Esparza-Trujillo; Ivane Bakhutashvili; Paul G Wakim; Michael T Kassin; Andrew L Lewis; John W Karanian; Bradford J Wood; William F Pritchard
Journal:  J Hepatocell Carcinoma       Date:  2021-03-09

8.  An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation.

Authors:  Jelena Djokic Kovac; Aleksandar Ivanovic; Tamara Milovanovic; Marjan Micev; Francesco Alessandrino; Richard M Gore
Journal:  Radiol Oncol       Date:  2021-01-29       Impact factor: 2.991

9.  Consensus on the secondary prevention of primary liver cancer.

Authors:  Yuemin Nan; Xiaoyuan Xu; Yanhang Gao; Rongqi Wang; Wengang Li; Ming Yang; Lingdi Liu; Zhongping Duan; Jidong Jia; Lai Wei; Hui Zhuang
Journal:  Hepatol Int       Date:  2021-11-30       Impact factor: 6.047

10.  Hepatobiliary phases in magnetic resonance imaging using liver-specific contrast for focal lesions in clinical practice.

Authors:  Daniel Alvarenga Fernandes; Eduardo Andreazza Dal Lago; Felipe Aguera Oliver; Bruna Melo Coelho Loureiro; Daniel Lahan Martins; Thiago José Penachim; Ricardo Hoelz de Oliveira Barros; José de Arimatéia Batista Araújo Filho; Larissa Bastos Eloy da Costa; Áurea Maria Oliveira da Silva; Elaine Cristina de Ataíde; Ilka de Fátima Santana Ferreira Boin; Nelson Marcio Gomes Caserta
Journal:  World J Hepatol       Date:  2022-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.